Key result
High-dose exercise training significantly improved VO2peak compared to low-dose training (mean difference 2.6 mL kg-1 min-1; 95% CI 0.4-4.8), with effects persisting at 12 months.
Why the study?
To determine whether a higher dose of exercise training in cardiac rehabilitation improves aerobic capacity and muscle strength.
Does a higher dose of exercise training improve VO2peak and muscle strength in cardiac patients referred to exercise-based cardiac rehabilitation?
RCT (n=164)
Assessor-blinded
randomized
No
Does a higher dose of exercise training improve VO2peak and muscle strength in cardiac patients referred to exercise-based cardiac rehabilitation?
Mean Difference: 2.6 (95% CI 0.4–4.8)
A higher dose of exercise training (36 vs 16 sessions) in cardiac rehabilitation yields small but persistent improvements in VO2peak and maximal workload at 12 months.
May support higher-dose exercise in cardiac rehab; hypothesis-generating until confirmed in RCTs.
Objective: To assess if a higher dose of exercise training in exercise-based cardiac rehabilitation could affect improvements in aerobic capacity and muscle strength. Design: Assessor-blinded randomized controlled trial with 12-months follow-up. Setting: Aarhus University Hospital, Aarhus, Denmark. Subjects: A total of 164 cardiac patients referred to exercise-based cardiac rehabilitation were recruited. Interventions: Patients were randomized to 1-hour exercise sessions either three times weekly for 12 weeks (36 sessions, high-dose group) or twice weekly for 8 weeks (16 sessions, low-dose group). The same standardized exercise and intensity protocol including aerobic and muscle strength training was used in all participants. Main measures: Primary outcome was changes in VO 2peak . Secondary outcomes were changes in maximal workload, muscle strength and power. Measures were obtained at baseline, after termination of the rehabilitation programme and at follow-up after 6 and 12 months. Results: After the end of intervention, statistically significant between-group differences were seen in favour of the high-dose group in all outcomes: VO 2peak 2.6 (mL kg −1 min −1 ) (95% confidence interval (CI): 0.4–4.8), maximal workload 0.3 W kg −1 (95%CI: 0.02–0.5), isometric muscle strength 0.7 N m kg −1 (95%CI: 0.1–1.2) and muscle power 0.3 W kg −1 (95%CI: 0.04–0.6). After 12 months, a significant between-group difference only persisted in VO 2peak and maximal workload. Conclusion: A higher dose of exercise training had a small effect on all outcomes at termination of intervention. A long-term effect persisted in VO 2peak and maximal workload. Although the effect was small, it is an important finding because VO 2peak is the most important predictor of all-cause mortality in cardiac patients.
No takes yet. Share an insight, caveat, or question.
Petersen et al. (2019) conducted an RCT in Cardiac patients referred to exercise-based cardiac rehabilitation (n=164). High-dose exercise training vs. Low-dose exercise training (1-hour exercise sessions twice weekly for 8 weeks, 16 sessions) was evaluated on Changes in VO2peak (MD 2.6, 95% CI 0.4-4.8). High-dose exercise training significantly improved VO2peak compared to low-dose training (mean difference 2.6 mL kg-1 min-1; 95% CI 0.4-4.8), with effects persisting at 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: